Benefit-risk balance of Covid drugs. New prospects

Elsevier

Available online 6 September 2022

TherapiesAbbreviationsCYP3A4

cytochrome P450 3A4

SARS-CoV

severe acute respiratory syndrome coronavirus

View full text

© 2022 Société française de pharmacologie et de thérapeutique. Published by Elsevier Masson SAS. All rights reserved.

留言 (0)

沒有登入
gif